Reliv Reports 2019 Q1 Results – Net Sales Down 7.3% to $7.1M

Reliv Reports 2019 Q1 Results - Net Sales Down 7.3% to $7.1M

Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today recently reported its financial results for the first quarter of 2019.

Reliv reported net sales of $9.5 million for the first quarter of 2019 compared with net sales of $10.0 million in the first quarter of 2018. Net sales in the United States decreased to $7.1 million in the first quarter of 2019, which represented a 7.3% decline in net sales when compared to the prior-year quarter.

Net sales in Reliv’s foreign markets increased 1.9% in the first quarter of 2019 compared with the prior-year first quarter.  Increases in net sales in Asia and Mexico were 57.9% and 27.1%, respectively, in the first quarter of 2019, offset by a decrease in net sales in Europe of 19.4%, along with decreases in other regions.

Reliv reported net income for the first quarter of 2019 of $624,000 (earnings per diluted share of $0.36) compared to a net loss of $238,000 (loss per diluted share of $0.13) in the first quarter of 2018.  The income from operations for the first quarter of 2019 was $199,000 compared to a loss from operations of $224,000 in the same period in 2018.

Results from operations were primarily impacted by a reduction of selling, general and administrative expenses (“SGA”), partially offset by the decline in net sales and gross margin.  SGA expenses decreased to $3.7 million in the first quarter of 2019 from $4.5 million in the first quarter of 2018.  Additionally, other income in the first quarter of 2019 includes a gain of $435,000 from the sale of manufacturing equipment as part of an asset sale with Nutracom, LLC.

On January 1, 2019, Reliv entered into a purchase agreement with Nutracom, LLC that included the sale of its manufacturing equipment and most of its raw material inventory.  In addition to the purchase agreement, Reliv entered into several other agreements with Nutracom, including a product supply agreement and a lease agreement, under which Nutracom will lease the manufacturing and warehouse space of Reliv’s headquarters building, along with a portion of the office space.

“We believe 2019 represents a year of innovation and growth,” commented Ryan A. Montgomery, Chief Executive Officer. 


“With our agreement with Nutracom and the Hastings family to operate the production facility, Reliv continues to enjoy the same high level of service, quality control, flexibility, and efficiencies prior to the transition, but it allows us to focus solely on our core business—providing an outstanding line of nutritional supplements through our independent distributors. 


We look forward to a number of transformational changes to Reliv this year, including a new product line on the horizon.”

In other developments in the United States, Reliv successfully rolled out a new feature to its compensation plan this March to pay wholesale profit to distributors on a weekly basis. “This feature rewards our best and most productive distributors a meaningful portion of their earnings almost immediately.  This provides them with the rewards of the compensation plan to use as they wish and the ability to reinvest in their business,” said Montgomery.

In international operations, sales and distributor activity in the Philippines and Mexico continue to accelerate.  “Our growth in these markets is driven by outstanding growth in our distributor and preferred customer base,” noted Montgomery.

Net sales in the Philippines grew by 68.8% in local currency in the first quarter of 2019, compared to the prior-year quarter, as the active distributor and preferred customer count across all of the Asia markets increased by 66%.  “We are very pleased by the pace of growth in the Philippines and are looking to replicate the strategies used there in our other Asia-Pacific markets,” said Montgomery.  “Clearly, it’s an exciting time for both of our Philippines and Mexico markets.”

Reliv had cash and cash equivalents of $2.4 million as of March 31, 2019, compared to $2.0 million as of December 31, 2018.  Net cash used in operating activities was $127,000 in the first quarter of 2019.

As of March 31, 2019, Reliv had 32,300 distributors and preferred customers – an increase of 0.6 percent from March 31, 2018 – of which 2,740 are Master Affiliate level and above.  The number of Master Affiliates decreased by 12.7 percent compared to the year-ago total.  Master Affiliate is the level at which distributors are eligible to earn generation royalties.

About Reliv International, Inc.

Reliv International, based in Chesterfield, MO, produces nutritional supplements that promote optimal nutrition. Reliv supplements address core nutrition and targeted solutions.Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, a soy peptide that works at the epigenetic level to promote optimal health. The company sells its products through an international network marketing system of independent distributors in 14 countries. Learn more about Reliv at, or on FacebookTwitter or Instagram.

Get more information, facts and figures about Reliv International, click here for the Reliv International overview.

Become a Recommended Distributor

Direct Selling Distributors, they are active professionals, who love to team up with you!

Write a comment

Connect with